The research followed the tenets of the Declaration of Helsinki and was approved by the institutional human experimentation committee of the School of Medicine of Ribeirão Preto. Informed consent was obtained from the subjects after explanation of the nature and possible consequences of the study.
Upper eyelid saccades and pursuit movements were monocularly recorded in two groups of subjects: a control group of 22 healthy adult subjects (11 females, 11 males; age range, 25–66 years; mean ± SD, 40.4 ± 12.96 years) and in 15 patients with Graves orbitopathy (13 females, 2 males; age range, 21–54 years; mean, 38.47 ± 9.2 years). Subjects in the control group had no systemic or ophthalmic diseases. All Graves patients were in the inactive phase of the disease. Eight patients were using antithyroid drugs, and seven were receiving thyroid hormones to control hypothyroidism secondary to hyperthyroidism therapy (thyroidectomy, thyroid irradiation, or both). No patient showed clinical evidence of lid lag (von Graefe sign), strabismus, diplopia, limitation of the vertical eye movements, or any previous eyelid or orbital surgery. Clinical data such as visual acuity, Hertel measurements, automatic perimetry, and orbital computed tomography were available for all patients.